02
Sep
Mumbai (Maharashtra) [India], September 2: A blood cancer diagnosis is abrupt and overwhelming. When families hear terms like Acute Myeloid Leukemia or Hodgkin Lymphoma, finding genuinely available and effective treatments becomes their immediate focus. Today, the landscape of hematological care in India is shifting dramatically from a one-size-fits-all chemotherapy approach to advanced, highly personalized therapies. Why Precision Treatment Changes the Odds Blood cancers do not behave uniformly. Acute Myeloid Leukemia (AML), for instance, progresses aggressively within weeks, demanding immediate, targeted attention. Conversely, Hodgkin Lymphoma is highly treatable, but the challenge lies in curing the disease without causing long-term toxicities from overtreatment.…
